Quantcast
Last updated on April 17, 2014 at 13:45 EDT

Latest cardiac imaging Stories

2013-04-23 08:34:22

PALO ALTO, Calif., April 23, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the 12th Annual Needham Healthcare Conference on Tuesday, April 30, 2013 at 9:40 AM ET at the Westin Grand Central Hotel in New York. David Levison, the company's President and Chief Executive Officer, will provide an overview of CardioDx and Corus(®) CAD, the only clinically validated gene expression test for...

2013-04-15 11:45:26

MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography, a new study indicates. The study included 69 patients who underwent an MDCT scan as well as transthoracic and transesophageal echocardiography before having a TAVI, said Dr. Vineeta Sethi, lead author of the study. TAVI is done to treat patients with severe aortic stenosis who are not surgical candidates....

2013-04-03 12:30:22

WILMINGTON, Del., April 3, 2013 /PRNewswire/ -- Molecular Imaging Services, Inc. (MIS) is pleased to announce that it has performed the first Rubidium-82 Myocardial Perfusion PET scan in its newly opened office at Omega Medical Center located in Newark, Delaware. Myocardial Perfusion PET Imaging is a powerful tool in the assessment of coronary artery disease (CAD) and has been shown to have clear advantages over conventional SPECT Myocardial Perfusion Imaging. The higher sensitivity,...

2013-03-25 08:27:37

- Additional Data Underscore the Value of Corus CAD in Improving Primary Care Providers' (PCP) Precision at Excluding the Diagnosis of Obstructive Coronary Artery Disease in Female Patients Early in the Diagnostic Pathway - PALO ALTO, Calif., March 25, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced data demonstrating that Corus(®) CAD, the only clinically validated gene expression test for the assessment of...

2013-03-11 08:27:27

- Study Found that Cardiologists Changed Their Diagnostic Testing Strategy in 60 Percent of Female Patients Following Corus CAD Testing - PALO ALTO, Calif., March 11, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced results of a prospective study that evaluated how Corus(®) CAD, a blood-based gene expression test, influenced cardiologists' patient management decisions in women with suspected obstructive coronary...

2013-02-19 08:33:29

PALO ALTO, Calif., Feb. 19, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the publication of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) study in Circulation: Cardiovascular Genetics, a journal of the American Heart Association. Results of the prospective, multi-center U.S. study showed that Corus(®) CAD, a blood-based gene expression test, demonstrated high accuracy with both...

2012-12-05 14:36:23

Pharmacological stress echo identifies donor hearts that would historically have been rejected Hearts previously rejected due to donors' age or other risk factors can now be declared viable for transplantation using pharmacological stress echo, according to research presented at EUROECHO and other Imaging Modalities 2012. The study1 was presented by Dr Tonino Bombardini from Pisa, Italy. EUROECHO and other Imaging Modalities 2012 is the annual meeting of the European Association of...

2012-11-28 00:21:55

CHICAGO, Nov. 28, 2012 /PRNewswire-USNewswire/ -- While obesity is considered a cardiovascular risk factor, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) showed that African-American patients with coronary artery disease (CAD) have much less fat around their hearts compared to Caucasian patients. "Prior evidence suggests that increased fat around the heart may be either an independent marker of CAD burden or a predictor of the...

2012-10-24 07:32:17

MIAMI, Oct. 24, 2012 /PRNewswire/ -- Vida Systems, a company focused on creating innovative training technologies, announced today the launch of its first product, VidaEcho, a software platform designed to teach the mechanics of echocardiography, before a practitioner ever encounters a live patient. "The field of structural heart intervention is growing rapidly, creating the need for advanced training options," said Russell Ivanhoe MD, company founder. "We look forward to bringing an array...

2012-09-07 02:24:11

BALTIMORE, Sept. 7, 2012 /PRNewswire/ -- A new survey reveals that cardiologists around the United States are seeing more patients than ever before, yet performing, on average, fewer advanced nuclear tests on those patients. The survey cites a change in the approach to the delivery of cardiovascular care, as well as continued concerns about economic conditions, as reasons for the decline. Despite the decline, the findings confirm cardiologists' are providing Americans with technology-based...


Latest cardiac imaging Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »